Tempus AI beats Q3 revenue estimates with $334.21M, narrows adjusted loss to $0.11 per share, and raises FY25 guidance to ...
Machine learning models using initial neuropsychological and neuropsychiatric clinical data accurately distinguished AD from bvFTD.
Ironically enough, his initial downfall had nothing to do with Daraprim. Soon after he became infamous, federal prosecutors ...
Clever Culture is bringing automation to pharma microbiology, with its AI tech now used by global heavyweights such as ...
President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...
The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.
AptarGroup is acquiring Brazilian plastics manufacturer Sommaplast to strengthen its position in the fast-growing Latin ...
The partnership combines Körber's PAS-X MES platform with Pepperl+Fuchs' VisuNet interfaces for secure and regulatory ...
The Indianapolis-based drugmaker said the supercomputer will power an "AI factory" designed to accelerate drug discovery and development.
The 21st edition of PharmaTech Expo & LabTech Expo, concurrent with Contract Manufacturing and Raw & Packaging Material Expo, is scheduled to take place from December 19 to 21, 2025, at the Bengaluru ...
GAITHERSBURG, Md., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results